Dilution of Share Value and Voting Rights Through the Exercise of Stock Acquisition Rights
First written in FY2021. 4 of 6 entries say "Mitigated", first in FY2022. Latest entry: FY2025.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「As of the filing date, the number of potential shares from stock acquisition rights was 154,468, equivalent to 4.3% of the 3,632,668 issued shares.」
The potential-share ratio declined from 4.9% to 4.3%, while the issuance of Series 11 stock acquisition rights added a new dilution factor. - FY2024MitigatedAnnual report
「As of the filing date, the number of potential shares from stock acquisition rights was 176,668, equivalent to 4.9% of the 3,618,928 issued shares.」
The potential-share ratio declined from 6.0% to 4.9%. - FY2024-Q2WorsenedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Stock acquisition rights for 14,800 shares were issued as the 10th series, adding a potential dilution factor. - FY2023MitigatedAnnual report
「As of the filing date, the number of potential shares from stock acquisition rights was 181,778, equivalent to 6.0% of the 3,010,278 issued shares.」
The potential-share ratio declined from 6.1% to 6.0%. - FY2022MitigatedAnnual report
「The number of potential shares from stock acquisition rights was 186,118, equivalent to 6.1% of the 3,006,178 issued shares.」
The potential-share ratio declined from 7.2% to 6.1%. - FY2021First statedAnnual report
「As of the filing date, the number of potential shares from stock acquisition rights was 216,338, equivalent to 7.2% of the 3,001,178 issued shares.」
The company discloses the potential shares and 7.2% dilution risk upon exercise.